Sridhar Priyanka, Wang Hong Yu, Velo Agostina, Nguyen Destiny, Singh Avinash, Rehman Abdul, Filopei Jason, Ehrlich Madeline, Lookstein Robert, Steiger David J
Department of Medicine, Icahn School of Medicine at Mount Sinai Health System, New York City, New York, USA.
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai Health System, New York City, New York, USA.
Res Pract Thromb Haemost. 2024 Oct 29;8(8):102606. doi: 10.1016/j.rpth.2024.102606. eCollection 2024 Nov.
Interhospital transfer (IHT) for acute pulmonary embolism (PE) is increasingly performed to improve access to advanced reperfusion therapies. It is unclear if outcomes of patients undergoing IHT are comparable with those of patients presenting in-house to hospitals with PE Response Team (PERT) capabilities.
To determine whether outcomes of patients with acute PE undergoing IHT differ from those of patients presenting in-house.
We retrospectively reviewed 386 patients with acute PE who were treated by PERT at 1 of 3 urban teaching hospitals in the Mount Sinai Health System in New York City from January 2021 to October 2023. Propensity score-weighted analysis was performed to compare the outcomes of patients managed in-house with those of patients undergoing IHT.
Two hundred eighty-four patients presented in-house, while 102 were transferred from other hospitals. Median PE Severity Index score was 84, and 3 (0.8%), 80 (20.7%), 237 (61.4%), and 66 (17.1%) had low-risk, intermediate low-risk, intermediate high-risk, and high-risk PE. Odds of receiving systemic thrombolysis (odds ratio [OR], 1.06; = .06) or advanced therapies (OR, 0.95; = .003) were not significantly different between the 2 groups. Rates of 30-day mortality, major bleeding, and readmission were 6.9%, 2.9%, and 9.8% for the IHT group and 10.6%, 2.1%, and 13% for the in-house group, respectively. IHT patients had lower odds of 30-day mortality (OR, 0.88; = .003) and higher odds of major bleeding (OR, 1.03; = .04).
PERT-guided IHT for patients with acute PE was associated with reduced mortality but increased risk of bleeding compared with patients managed in-house at hospitals with PERT capabilities.
急性肺栓塞(PE)的院间转运(IHT)越来越多地用于改善获得高级再灌注治疗的机会。目前尚不清楚接受IHT的患者的结局与在具备肺栓塞应对团队(PERT)能力的医院内就诊的患者的结局是否可比。
确定急性PE患者接受IHT的结局与在医院内就诊的患者的结局是否不同。
我们回顾性分析了2021年1月至2023年10月在纽约市西奈山医疗系统的3家城市教学医院之一接受PERT治疗的386例急性PE患者。进行倾向评分加权分析,以比较在医院内接受治疗的患者与接受IHT的患者的结局。
284例患者在医院内就诊,102例从其他医院转运而来。PE严重程度指数中位数为84,3例(0.8%)、80例(20.7%)、237例(61.4%)和66例(17.1%)为低风险、低中风险、高中风险和高风险PE。两组接受全身溶栓治疗(比值比[OR],1.06;P = .06)或高级治疗(OR,0.95;P = .003)的几率无显著差异。IHT组30天死亡率、大出血和再入院率分别为6.9%、2.9%和9.8%,医院内就诊组分别为10.6%、2.1%和13%。IHT患者30天死亡率的几率较低(OR,0.88;P = .003),大出血的几率较高(OR,1.03;P = .04)。
与在具备PERT能力的医院内接受治疗的患者相比,PERT指导下的急性PE患者IHT与死亡率降低但出血风险增加相关。